The 14 references in paper A. Vatazin V., E. Shilov M., N. Khozyainova Y., V. Ermolenko M., A. Zemchenkov Y., A. Essaian M., L. Morgunov Y., N. Mikhailova A., A. Smolyakov A., M. Samsonov Y., Андрей Ватазин Владимирович, Евгений Шилов Михайлович, Наталья Хозяинова Юрьевна, Валентин Ермоленко Михайлович, Александр Земченков Юрьевич, Ашот Есаян Мовсесович, Леонид Моргунов Юльевич, Наталия Михайлова Алексеевна, Александр Смоляков Александрович, Михаил Самсонов Юрьевич (2016) “Новые возможности коррекции гиперкалимии у пациентов с хронической болезнью почек // New possibilities of correction of hyperkalemia in patients with chronic kidney disease” / spz:neicon:nefr:y:2016:i:4:p:47-53

1
Смирнов АВ, Шилов ЕМ, Добронравов ВА и соавт. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. «Левша. Санкт-Петербург», 2012. 51с [Smirnov AV, Shilov EM, Dobronravov VA i soavt. Natcional`ny`e rekomendatcii. KHronicheskaia bolezn` pochek: osnovny`e printcipy` skrininga, diagnostiki, profilaktiki i podhody` k lecheniiu. «Levsha. Sankt-Peterburg», 2012. 51s]
(check this in PDF content)
2
Hsieh MF, Wu IW, Lee CC et al. Higher serum potassium level associated with late stage chronic kidney disease. Chang Gung Med J 2011; 34: 418-425
(check this in PDF content)
3
Elliott MJ, Ronksley PE, Clase CM et al. Management of patients with acute hyperkalemia. CMAJ 2010; 182: 1631-1635
(check this in PDF content)
4
Evans BM, Jones NC, Milne MD et al. Ion-exchange resins in the treatment of anuria. Lancet 1953; 265: 791-795
(check this in PDF content)
5
Sterns RH, Rojas M, Bernstein P et al. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 2010; 21: 733-735
(check this in PDF content)
6
Nepal M, Bucaloiu ID, Norfolk ER. Hypernatremia in a patient treated with sodium polystyrene sulfonate. Int J Nephrol Renovasc Dis 2010; 3: 141-143
(check this in PDF content)
7
Chernin G, Gal-Oz A, Ben-Assa E et al. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy. Clin Cardiol 2012; 35: 32-36
(check this in PDF content)
8
Смирнов АВ, Кучер АГ, Каюков ИГ, Есаян АМ. Руководство по лечебному питанию для больных с хронической болезнью почек. СПб-Тверь: Триада, 2009 [Smirnov AV, Kucher AG, Kaiukov IG, Esaian AM. Rukovodstvo po lechebnomu pitaniiu dlia bol`ny`kh s khronicheskoi` bolezn`iu pochek. SPb-Tver`: Triada, 2009]
(check this in PDF content)
9
Sarafidis PA, Blacklock R, Wood E et al. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol 2012; 7: 1234-1241
(check this in PDF content)
10
Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract 2012; 14: 1-17
(check this in PDF content)
11
Wakabayashi M, Shou I. Study on the dose response of a jelly preparation of polystyrene sulfonate calcium in hyperkalemia. Ther Res 2005; 1727-1733
(check this in PDF content)
12
Tomino Y, Yamazaki T, Shou I et al. Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia-changes in serum potassium levels with or without a RAAS inhibitor. Clin Nephrol 2007; 68: 379-385
(check this in PDF content)
13
Lagunas-Munoz J, Méndez-Durán A, Pérez-Grovas H et al. Eficacia y seguridad de poliestireno sulfonato calcico en hiperkalemia en pacientes con enfermedad renal cronica. Arch de Med de Urg de Mexico 2010; 2 (1): 12-16
(check this in PDF content)
14
Xiao LI, Gang XU, Hong-li LIN et al. Calcium Polystyrene Sulfonate in Treating Hyperkalemia Patients with Chronic Kidney Disease: Multi-center Clinical Study. Chin J Nephrol 2013; 29(6): 18-22 Сведения об авторах:
(check this in PDF content)